Majority of Britons now ‘self indentify' as neurodivergent
Francesca Happé, professor of cognitive neuroscience at the Institute of Psychiatry, Psychology and Neuroscience at King's College London, said reduced stigma around these conditions had led more people both to seek medical diagnoses and to self-diagnose.
She said: 'There's a lot more tolerance, which is good — particularly among my children's generation, who are late teens and early adults, where people are very happy to say 'I'm dyslexic', 'I'm ADHD [attention deficit hyperactivity disorder]'.'
Happé said there was a risk, however, that behaviour that would have been thought of only as 'a bit of eccentricity' in the past has now
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BreakingNews.ie
3 hours ago
- BreakingNews.ie
Children prescribed anti psychotic drug while in CAMHS care settle actions
Two teenagers who were prescribed an anti-psychotic drug while undergoing treatment with the South Kerry Child and Adolescent and Mental Health Services have settled their High Court actions for a total of €140,000. In one of the cases, the then almost 10-year-old boy gained 3.5kg in weight in the six months he was on the drug, Risperidone, which the High Court heard was not appropriate and should not have been prescribed. Advertisement They had sued the HSE over the care they received at South Kerry Child and Adolescent Mental Health Services (CAMHS). None of the children can be identified by order of the court. The settlements were reached after mediation. Robert Fitzpatrick SC with Siun Leonowicz BL told the court that the first boy had been referred to the CAMHS service when he was under ten years of age, and he was prescribed the anti-psychotic drug Risperidone. Counsel said the drug should never have been prescribed, and it was dispensed for another five months in 2019. The young boy, he said, suffered side effects including weight gain, and he had gained 3.5 kg in weight over a 23-week period. At one stage, counsel said the boy was prescribed an appetite suppressant medication, which counsel said was also inappropriate. Mr Fitzpatrick said the appetite suppressant medication appeared to be given in a misplaced effort to counteract the Risperidone, which should not have been prescribed. Counsel described it as a 'case of double error.' Advertisement Approving a €65,000 settlement in the teenager's case, Mr Justice Paul Coffey said it was fair and reasonable, and he wished the boy the best for the future. In the second case, a 16-year-old boy settled his action for €75,000. Counsel said the boy, when he was nine years old, had been put on Risperidone and was taking it for five months in 2018. Counsel said the anti-psychotic was never appropriate for the child. Counsel said the boy had been put on an ADHD medication, which he had taken before and from which he previously suffered side effects. By putting the boy on the ADHD drug again, counsel said he had been needlessly put through side effects. Approving the settlement, Mr Justice Paul Coffey conveyed his best wishes to the teenager. Advertisement In another case, a 16-year-old boy was awarded €17,500 in relation to his care at South Kerry CAMHS. Counsel told the court that the boy, when he was six years old, had been assessed by the service, diagnosed with ADHD and started on medication. Counsel said his case related to a 23-month gap in later follow-up. At one stage, counsel said the boy was prescribed the anti-psychotic drug Risperidone, but thanks 'to the good sense of his father, he never gave him the medication.' His case solely related to lost follow-up.
Sky News
3 hours ago
- Sky News
Can anything stop the ketamine crisis?
👉 Listen to Sky News Daily on your podcast app 👈 Incontinence and chronic pain are just some of the life-altering effects caused by heavy ketamine use - which is at record levels. The drug, used in clinical settings as an anaesthetic, sedative and pain reliever, can create hallucinations in users. But those who become addicted to ketamine also face severe bladder and kidney problems. As the government considers reclassifying ketamine to a Class A substance, Shingi Mararike, our North of England correspondent, has been speaking to people suffering life-changing health consequences, and the people trying to help them. He joins Niall Paterson on the Sky News Daily to share more about the use of the drug. Plus, Dr Caroline Copeland, a senior lecturer in pharmacology and toxicology at King's College London and director of the National Programme on Substance Use Mortality, talks to Niall about why the discussion on ketamine needs to go beyond criminalisation.
Daily Mail
4 hours ago
- Daily Mail
More than 22million Americans suffering from ADHD have higher risk of developing deadly brain disease
The 22million Americans with attention-deficit/hyperactivity disorder could be more likely to develop early-onset dementia, a preliminary study suggests. Researchers at the University of Pittsburgh analyzed health records from people diagnosed with ADHD as children in the 1980s and 90s. These patients were then followed into adulthood and are now in their 40s. They found adults living with ADHD scored worse on cognitive tests looking at executive function, complex tasks, word recall and working memory. These patients also had higher levels of toxic proteins directly shown to cause Alzheimer's disease, the most common form of dementia that affects 7million Americans. The researchers said the findings of the study, which is still recruiting for larger experiments, are particularly noteworthy because participants were all under 50, suggesting early-onset disease. While they are unsure what exactly causes the elevated risks, the team suggests it could be due to individuals with ADHD having less brain capacity for age-related degeneration. They also pointed toward issues like diabetes and obesity, dementia risk factors, being more prevalent in ADHD populations. ADHD is a neurodevelopmental disorder that affects focus, impulse control, and energy levels. The CDC estimates one in 10 children in the US have been diagnosed with the condition, totaling about 7million, according to the latest data available. About 15.5million adults have the disorder. The researchers recruited 25 people who were originally part of the Pittsburgh ADHD Longitudinal Study (PALS) at the University of Pittsburgh between 1987 and 1996. Children were observed during an eight-week summer camp and diagnosed with ADHD. All of them were then followed into adulthood. The average participant age is 44 and eight in 10 are men. Participants were given blood tests to detect amyloid and tau, toxic proteins that accumulate in the brain and form plaques, destroying brain cells and causing dementia. The blood tests also measured inflammation and signs of cardiovascular disease, which can damage blood vessels and block blood flow. The researchers found participants with ADHD scored lower on tests measuring executive function and processing speed, which are how the brain handles problem solving and how quickly it takes in information. They also scored worse on working memory tests and recalled fewer words than people without ADHD. Most surprising to the researchers was higher levels of dementia-causing proteins in blood samples from ADHD patients, suggesting early signs of Alzheimer's disease. Dr Brooke Molina, study author and director of the Youth and Family Research Program at the University of Pittsburgh, said during a conference presentation: 'We found bigger differences than we expected to see at this age. Remember, the mean age is 44 and it's a fairly tight age range. These are all individuals in their early to mid 40s. 'We are seeing elevate Alzheimer's disease risk. What's going to happen with that as they age?' While it's unclear exactly why people with ADHD are at a greater risk of dementia, researchers suggest it could be because these individuals have a diminished 'brain reserve.' This means their brain's capacity to compensate for age-related changes or neurodegenerative processes is diminished, making them more vulnerable to dementia. Dr Molina also noted people with ADHD are at a higher risk of vascular conditions like high blood pressure, diabetes and obesity due to stimulant medications and a greater chance of unhealthy lifestyle factors. The experts are still recruiting for larger scale research, as the small sample size was the study's main limitation. Dr Molina said: 'There is lots more that we can do once we finish collecting the data.'
